U.S. Sen. Josh Hawley, R-Mo., talks to reporters at the U.S. Capitol on Saturday, June 28, 2025. (Photo by Ashley Murray/States Newsroom)

WASHINGTON — Vice President JD Vance broke a tied Senate vote to block advancement of a war powers resolution that would have stopped President Donald Trump from taking further military action against Venezuela without congressional authorization.

Senate Republicans used a procedural maneuver Wednesday night to halt debate on the Vietnam War-era statute that gives Congress a check on the president’s deployments abroad. 

Sens. Todd Young of Indiana and Josh Hawley of Missouri flipped on their previous votes to advance the resolution, splitting support at 50-50 — and delivering a victory to Trump, who had strongly criticized Republican senators who earlier defected from the administration.

Sens. Lisa Murkowski of Alaska, Susan Collins of Maine and Rand Paul of Kentucky voted to keep the effort alive in the Senate. Paul is the only Republican co-sponsor of the bill. Democratic Sen. Tim Kaine of Virginia was the leading Democratic co-sponsor.

Young said while he “strongly” believes Congress must be involved in any decisions about the commitment of U.S. troops, administration officials assured him that is not the state of play in Venezuela.

“After numerous conversations with senior national security officials, I have received assurances that there are no American troops in Venezuela. I’ve also received a commitment that if President Trump were to determine American forces are needed in major military operations in Venezuela, the Administration will come to Congress in advance to ask for an authorization of force,” Young said in a written statement after he cast his vote.

Rare rebuke doesn’t last

The vote came less than a week after Young and Hawley were among the  five Senate Republicans who broke with party ranks to move the resolution across an initial procedural hurdle — a rare rebuke of Trump from some in his own party.

Trump pointedly attacked the five GOP senators after they voted, writing on his Truth Social platform that the lawmakers “should never be elected to office again.” 

Senate Republicans argued a resolution to rein in Trump’s military actions against Venezuela is not relevant because “there’s no troops there, there is nothing to terminate,” as Senate Foreign Relations Committee Chair Jim Risch said on the floor ahead of the vote.

“Now, I know some of my colleagues will argue that a vote for this resolution is a prospective statement about limiting future action in Venezuela. That’s not what it says. They argue, ‘we still have ships in the Caribbean, and clearly the president is ready to invade again,’ they say. But again, that is not what the resolution says. … No language in this resolution addresses future action,” said Risch, R-Idaho, who moved to table the measure.

The vote came 11 days after U.S. special forces apprehended Venezuela’s president, Nicolás Maduro, and his wife, Cilia Flores, from their bedroom during a surprise overnight raid. The couple was wanted by U.S. authorities on federal drug and conspiracy charges.

The vote also comes after a monthslong bombing campaign on small boats in the Caribbean Sea and eastern Pacific Ocean in which U.S. strikes killed more than 115 alleged “narco-terrorists,” according to U.S. Southern Command.

Within an hour before senators voted to block any advancement of the war powers resolution, Trump posted on social media that he “had a very good call” Thursday morning with Venezuela’s interim President Delcy Rodríguez.

“We are making tremendous progress, as we help Venezuela stabilize and recover. Many topics were discussed, including Oil, Minerals, Trade and, of course, National Security. This partnership between the United States of America and Venezuela will be a spectacular one FOR ALL. Venezuela will soon be great and prosperous again, perhaps more so than ever before!” Trump wrote on his own platform, Truth Social.

Trump hosted oil executives at the White House Friday for a meeting on potential investment in Venezuela’s oil industry. Prior to the meeting, the president announced the South American nation had already agreed to give the U.S. between 30 million and 50 million barrels of oil. Trump said he would control the money made from the sale.

‘We are heavily engaged’

Paul and Democratic sponsors of the war powers resolution vehemently disagreed with the GOP statements about the U.S. presence in and around Venezuela.

“You don’t have to be a great expert in military affairs to know that we are heavily engaged,” said Senate Minority Leader Chuck Schumer, a New York Democrat, ahead of the vote.

“Donald Trump says we’re not engaged in hostilities? Tell that to the 16,000 U.S. service members currently deployed in the Caribbean. Tell that to our service members on the Ford carrier strike force. Look at the Marine expeditionary unit operating in the region,” Schumer said. “Donald Trump is turning the Caribbean into a dangerous powder keg — and Congress must rein him in before one mistake ignites a larger, more unstable conflict.”

Kaine likened the Republicans’ procedural move to “a parliamentary gag rule on discussion of this military operation.”

“If this cause and if this legal basis were so righteous and so lawful, the administration and its supporters would not be so afraid to have this debate before the public and the United States Senate,” Kaine said on the floor ahead of the vote.

Paul said the administration’s claim that Venezuela is not an official war is “an absurdity.”

“The invasion of another country, blockading of a country and removing another country’s leader, to my mind, clearly, is war,” Paul said on the floor ahead of the vote.

U.S. Southern Command declined to confirm Wednesday the exact number of troops and warships present in the region.

Venezuelan Interior Minister Diosdado Cabello said more than 100 were killed in the raid, according to numerous media outlets that posted a video of his statement. The Cuban government announced on Facebook 32 of its citizens were among the dead.

Seven U.S. troops were injured in the incursion, according to the Pentagon. Five returned to work within days after the attack, while two were still recovering as of Jan. 8. Pentagon officials declined to comment further on their conditions Wednesday.

Louisiana Republican U.S. Sen. Bill Cassidy speaks during a press conference on Wednesday, Jan. 14, 2026. Also pictured, from left, are Family Foundation of Virginia President Victoria Cobb, National Association of Christian Lawmakers Founder and President Jason Rapert, Family Research Council President Tony Perkins, Ohio Attorney General Dave Yost, Louisiana Attorney General Liz Murrill and Missouri Republican U.S. Sen. Josh Hawley. (Photo by Jennifer Shutt/States Newsroom)

WASHINGTON — Republicans on a key U.S. Senate committee on Wednesday called on the Food and Drug Administration to wrap up its ongoing safety review of medication abortion and pressed for the Trump administration to once again require in-person dispensing.

Democrats on the Health, Education, Labor and Pensions Committee argued women, not politicians, are in the best position to determine whether to ask for a prescription for mifepristone. 

Louisiana Republican Sen. Bill Cassidy, chairman of the panel, said he hopes FDA Commissioner Marty Makary will agree to testify before the committee on the process in the future, though he didn’t set a deadline.  

“At an absolute minimum, the previous in-person safeguards should be restored and it should be done immediately,” Cassidy said. 

Republicans and anti-abortion organizations have become increasingly skeptical about the FDA’s review after news broke in December that Makary wanted to delay its release until after the November midterm elections. 

Washington Democratic Sen. Patty Murray questioned Cassidy’s reasons for holding the hearing, saying more than “160 high-quality studies have been conducted and millions of women around the world use mifepristone safely every year with fewer complications, by the way, than Viagra or penicillin.” 

Supreme Court case

Access to mifepristone, one of two pharmaceuticals used in medication abortion, which is FDA-approved for up to 10 weeks gestation, surged to the forefront after the U.S. Supreme Court ended the nationwide right to abortion in 2022. 

Many Republican state legislatures have moved to bar access to mifepristone for abortions, while Democratic states have enacted shield laws to protect health care providers who prescribe and ship it to people in states with limited or no access. 

Dr. Nisha Verma, a fellow at Physicians for Reproductive Health in Atlanta, testified before the committee that “the science on mifepristone’s safety and effectiveness is long-standing and settled.”

“Over the past 25 years, medication abortion using mifepristone and misoprostol has been rigorously studied and proven safe and effective in over 100 high-quality, peer-reviewed studies,” Verma said. “Extensive data show that medication abortion through telehealth is equally safe and effective and provides vital access for those who live in rural areas and in the growing number of maternity care deserts in the country.”

Verma contended the likely reason for the hearing was not genuine concern from Republicans about the safety and efficacy of mifepristone but “because people in this room feel uncomfortable with abortion.”

“And that’s okay, and we can talk about that,” Verma said. “And we can have an honest conversation about that and complexity and the reasons that my patients need abortion care. But we should not pretend that this is an issue of the science.”

Louisiana attorney general testifies

Louisiana Attorney General Elizabeth Murrill, a Republican, criticized the FDA’s decision during the Biden administration to allow prescriptions via telehealth and for the pharmaceuticals to be shipped, sometimes into states that bar their use. 

“Shield laws in some states protect providers from liability and effectively nullify laws in other states,” Murrill said. “Their purpose is to make it more difficult to sue or prosecute individuals in those states.”

Indiana Republican Sen. Jim Banks expressed frustration that FDA Commissioner Makary was not among the witnesses testifying at the hearing and urged the agency to release the results of its review of mifepristone quickly. 

“I’m disappointed that the FDA under Dr. Makary’s leadership hasn’t moved faster to restore the in-person dispensing requirement and strengthen the (Risk Evaluation and Mitigation Strategies) program for mifepristone,” Banks said. “I hope the rumors are false, some of them are in print, that the agency is intentionally slow-walking its study on mifepristone health risks.”

Emily G. Hilliard, press secretary for the Department of Health and Human Services, which includes the FDA, wrote in a statement the department “is conducting a study of reported adverse events associated with mifepristone to assess whether the FDA’s risk mitigation program continues to provide appropriate protections for women.”

“The FDA’s scientific review process is thorough and takes the time necessary to ensure decisions are grounded in gold-standard science,” Hilliard wrote. “Dr. Makary is upholding that standard as part of the Department’s commitment to rigorous, evidence-based review.”

Cassidy said after Banks raised his concerns that he hopes to have Makary testify “before the committee very soon and we’ve been speaking with the FDA to facilitate discussion on this and other issues.”

Cassidy added that HHS Secretary Robert F. Kennedy Jr. “did promise to come back and we have requested that he come back and testify.” 

Republicans, Family Research Council urge action by FDA

During a press conference after the hearing, Cassidy joined a handful of other GOP lawmakers and Family Research Council President Tony Perkins to further press the Trump administration to change the prescription guidelines for mifepristone. 

Perkins said the Trump administration could change FDA guidelines around how mifepristone is prescribed and distributed “overnight” if it wanted to. 

He also said it should immediately begin enforcing The Comstock Act, an 1873 law that could block shipping medication abortion.

“This is a two-step solution. One, is the in-person requirement being reestablished, the medical examinations to ensure that the women, their lives, are not put at risk,” Perkins said. “But then also … simply enforcing the law as it pertains to Comstock.”

Senate Majority Leader John Thune, R-S.D., center, joined by Senate Majority Whip John Barrasso, R-Wyo., left, and Sen. James Lankford, R-Okla., speaks to reporters following a Senate Republican policy luncheon at the U.S. Capitol on Dec. 9, 2025 in Washington, D.C.  (Photo by Heather Diehl/Getty Images)

WASHINGTON — The U.S. Senate in long-anticipated votes failed to advance legislation Thursday that would have addressed the rising cost of health insurance, leaving lawmakers deadlocked on how to curb a surge in premiums expected next year. 

Senators voted 51-48 on a Republican bill co-sponsored by Louisiana Sen. Bill Cassidy and Idaho Sen. Mike Crapo that would have provided funding through Health Savings Accounts for some ACA marketplace enrollees during 2026 and 2027. 

They then voted 51-48 on a measure from Democrats that would have extended enhanced tax credits for people who purchase their health insurance from the Affordable Care Act Marketplace for three years. A group of Senate Democrats in November agreed to end a government shutdown of historic length in exchange for a commitment by Republicans to hold a vote on extending the enhanced subsidies.

Republican Sens. Susan Collins of Maine, Lisa Murkowski and Dan Sullivan of Alaska voted for the Democrats’ bill. Sen. Rand Paul, R-Ky., voted against both bills. 

Neither bill received the 60 votes needed to advance under the Senate’s legislative filibuster rule. 

Senate Majority Leader John Thune, R-S.D., criticized the ACA marketplace and the subsidies for leading to large increases in the costs of health insurance. 

“Under Democrats’ plan insurance premiums will continue to spiral, American taxpayers will find themselves on the hook for ever-increasing subsidy payments,” Thune said. “And don’t think that all those payments are going to go to vulnerable Americans.”

Thune argued Democrats’ bill was only an extension of the “status quo” of a “failed, flawed, fraud program that is increasing costs at three times the rate of inflation. 

Thune said the Republican bill from Cassidy and Crapo would “help individuals to meet their out-of-pocket costs and for many individuals who don’t use their insurance or who barely use it, it would allow them to save for health care expenses down the road.”

Schumer calls GOP plan ‘mean and cruel’

Senate Minority Leader Chuck Schumer, D-N.Y., said the three-year extension bill was the only option to avoid a spike in costs for people enrolled in ACA marketplace plans. 

“By my last count, Republicans are now at nine different health care proposals and counting. And none of them give the American people the one thing they most want — a clean, simple extension of these health care tax credits,” Schumer said. “But our bill does extend these credits cleanly and simply and it’s time for Republicans to join us.”

Schumer referred to the Cassidy-Crapo proposals as “stingy” as well as “mean and cruel.”

“Under the Republican plan, the big idea is essentially to hand people about $80 a month and wish them good luck,” Schumer said. “And even to qualify for that check, listen to how bad this is, Americans would be forced onto bare-bones bronze plans with sky-high deductibles; $7,000 or $10,000 for an individual, tens of thousands for a couple.”

After the votes failed, Schumer outlined some of the guardrails Democrats would put in place regarding negotiations with GOP colleagues.

“They want to talk about health care in general and how to improve it — we’re always open to that, but we do not want what they want — favoring the insurance companies, favoring the drug companies, favoring the special interests and turning their back on the American people,” he said. 

Health Savings Accounts in GOP plan

The Cassidy-Crapo bill would have the Department of Health and Human Services deposit money into Health Savings Accounts for people enrolled in bronze or catastrophic health insurance plans purchased on the ACA marketplace in 2026 or 2027, according to a summary of the bill. 

Health Savings Accounts are tax-advantaged savings accounts that consumers can use to pay for medical expenses that are not otherwise reimbursed. They are not health insurance products.

ACA marketplace enrollees who select a bronze or catastrophic plan and make up to 700% of the federal poverty level would receive $1,000 annually if they are between the ages of 18 and 49 and $1,500 per year if they are between the ages of 50 and 64. 

That would set a threshold of $109,550 in annual income for one person, or $225,050 for a family of four, according to the 2025 federal poverty guidelines. The numbers are somewhat higher for residents of Alaska and Hawaii.  

The funding could not go toward abortion access or gender transitions, according to the Republican bill summary. 

Members of Congress have introduced several other health care proposals, including two bipartisan bills in the House that would extend the enhanced ACA marketplace tax credits for at least another year with some modifications. 

Speaker Mike Johnson, R-La., has been reluctant to bring either bipartisan bill up for a floor vote, though he may not have the option if a discharge petition filed earlier this week garners the 218 signatures needed. 

Pennsylvania Republican Rep. Brian Fitzpatrick wrote in a statement the legislation represents a “solution that can actually pass—not a political messaging exercise.”

“This bill delivers the urgent help families need now, while giving Congress the runway to keep improving our healthcare system for the long term,” Fitzpatrick wrote. “Responsible governance means securing 80 percent of what families need today, rather than risking 100 percent of nothing tomorrow.”

But Johnson said Wednesday that he will put a package of bills on the House floor next week that he believes “​​will actually reduce premiums for 100% of Americans who are on health insurance.” Details of those bills have not been disclosed.

Thune told reporters that if “somebody is successful in getting a discharge petition and a bill out of the House, obviously we’ll take a look at it. But at the moment, you know, we’re focused on the action here in the Senate, which is the side-by-side vote we’re going to have later today.” 

Alaska’s Murkowski said lawmakers can find a compromise on health care by next week “if we believe it is possible.”

Political costs

The issue of affordability and rising health care costs is likely to be central to the November midterm elections, where Democrats hope to flip the House from red to blue and gain additional seats in the Senate. 

The Democratic National Committee isn’t waiting to begin those campaigns, placing digital ads in the hometown newspapers of several Republicans up for reelection next year, including Maine’s Collins and Ohio’s Jon Husted. 

“Today’s Senate vote to extend the ACA tax credits could be the difference between life and death for many Americans,” DNC Chair Ken Martin said in a press release. “Over 20 million Americans will see their health care premiums skyrocket next year if Susan Collins, John Cornyn, Jon Husted, and Dan Sullivan do not stand with working families and vote to extend these lifesaving credits.”

White House press secretary Karoline Leavitt blasted Senate Democrats’ proposal during Thursday’s press briefing, calling it a “political show vote” meant to provide cover for Democrats, whom she blamed for creating the problem. 

Trump and Republicans would “unveil creative ideas and solutions to the health care crisis that was created by Democrats,” she said. “Chuck Schumer is not sincerely interested in lowering health care costs for the American people. He’s putting this vote on the floor knowing that it will fail so he can have another talking point that he can throw around without any real plan or action.”

Shauneen Miranda and Jacob Fischler contributed to this report.